Serrano MedTech Announces Headquarters Relocation to Chengdu and Files IPO Prospectus

Source: Securities Times

People's Finance News, February 7th: According to Chengdu Release, recently, Chengdu Silara Medtech Inc. (referred to as "Silara Medtech") officially signed to settle in Chengdu Tianfu International Bio City. It is reported that Silara Medtech plans to build its corporate headquarters, R&D center, and production base in the Bio City, systematically carrying out the research, development, production, and sales of medical devices in the field of structural heart disease.